Innate Pharma(IPHA) - 2024 Q1 - Earnings Call Transcript

Innate Pharma S.A. (NASDAQ:IPHA) Q1 2024 Results Conference Call May 14, 2024 8:00 AM ET | --- | |-------------------------------------------------| | | | Henry Wheeler - Head, Investor Relations | | Herve Brailly - Interim Chief Executive Officer | | Sonia Quaratino - Chief Medical Officer | | Yannis Morel - Chief Operating Officer | | Arvind Sood - EVP, U.S. Operations | | Frederic Lombard - Chief Financial Officer | | Conference Call Participants | | Daina Graybosch - Leerink Partners | | Yigal Nochomovi ...